Clinical Trial: Circulating Tumor DNA in High Risk Localized Prostate Cancer

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222436) titled 'Circulating Tumor DNA in High Risk Localized Prostate Cancer' on Oct. 27.

Brief Summary: This prospective, non-therapeutic translational biomarker study will collect blood in patients with high risk localized prostate cancer prior to prostatectomy.

Study Start Date: Sept. 23

Study Type: OBSERVATIONAL

Condition: Prostate Cancer

Recruitment Status: RECRUITING

Sponsor: University of Pittsburgh

Information provided by (Responsible Party): Leonard Appleman, University of Pittsburgh

Disclaimer: Curated by HT Syndication....